These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 38251358)

  • 1. Pathogen Discovery in the Post-COVID Era.
    Guo C; Wu JY
    Pathogens; 2024 Jan; 13(1):. PubMed ID: 38251358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of the COVID-19 pandemic on Chinese assisted reproductive technology institutions and human sperm banks: reflections in the post-pandemic era.
    Wei L; Zhang J; Deng X; Luo C; Bo L; Gao S; Qian F; Lu S; Mao C
    J Health Popul Nutr; 2023 Aug; 42(1):82. PubMed ID: 37592335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prospects of public health at COVID-19 post-pandemic stage].
    Li LM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jul; 42(7):1143-1147. PubMed ID: 33874702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prototype Pathogen Approach for Vaccine and Monoclonal Antibody Development: A Critical Component of the NIAID Plan for Pandemic Preparedness.
    Cassetti MC; Pierson TC; Patterson LJ; Bok K; DeRocco AJ; Deschamps AM; Graham BS; Erbelding EJ; Fauci AS
    J Infect Dis; 2023 Jun; 227(12):1433-1441. PubMed ID: 35876700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How many human pathogens are there in Laos? An estimate of national human pathogen diversity and analysis of historical trends.
    Clarkson MC; Aguas R; Sweet K; Roberts T; Strobel M; Newton PN
    BMJ Glob Health; 2020 Oct; 5(10):. PubMed ID: 33093128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation and challenges to preventing the re-establishment of malaria in China in the COVID-19 era.
    Lu G; Cao Y; Zhang D; Zhang Y; Xu Y; Lu Y; Chen Q; Zhu G; Yan J; Müller O; Cao J
    Global Health; 2022 Jun; 18(1):64. PubMed ID: 35729642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovations in infectious disease testing: Leveraging COVID-19 pandemic technologies for the future.
    Tran NK; Albahra S; Rashidi H; May L
    Clin Biochem; 2023 Jul; 117():10-15. PubMed ID: 34998789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A determination of pan-pathogen antimicrobials?
    Prathapan P
    Med Drug Discov; 2022 Jun; 14():100120. PubMed ID: 35098103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Scenario of Pathogen Detection Techniques in Agro-Food Sector.
    Nehra M; Kumar V; Kumar R; Dilbaghi N; Kumar S
    Biosensors (Basel); 2022 Jul; 12(7):. PubMed ID: 35884292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of virtual and augmented reality in infectious disease epidemics with a focus on the COVID-19 outbreak.
    Asadzadeh A; Samad-Soltani T; Rezaei-Hachesu P
    Inform Med Unlocked; 2021; 24():100579. PubMed ID: 33937503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outlook of pandemic preparedness in a post-COVID-19 world.
    Williams BA; Jones CH; Welch V; True JM
    NPJ Vaccines; 2023 Nov; 8(1):178. PubMed ID: 37985781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reflections on the Global Pandemic of COVID-19 and the Response Strategies].
    Lu Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Nov; 52(6):936-938. PubMed ID: 34841757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comprehensive Review on Cardiovascular Complications of COVID-19: Unraveling the Link to Bacterial Endocarditis.
    Bele A; Wagh V; Munjewar PK
    Cureus; 2023 Aug; 15(8):e44019. PubMed ID: 37746510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applied Bioinformatics and Public Health Microbiology: challenges, discoveries and innovations during a pandemic.
    Cunningham-Oakes E; Trivett H
    Microb Genom; 2022 Jan; 8(1):. PubMed ID: 35098917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next Generation Sequencing and Bioinformatics Methodologies for Infectious Disease Research and Public Health: Approaches, Applications, and Considerations for Development of Laboratory Capacity.
    Maljkovic Berry I; Melendrez MC; Bishop-Lilly KA; Rutvisuttinunt W; Pollett S; Talundzic E; Morton L; Jarman RG
    J Infect Dis; 2020 Mar; 221(Suppl 3):S292-S307. PubMed ID: 31612214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Concepts and Technologies for the Discovery of Microorganisms Involved in Human Disease.
    Bullman S; Meyerson M; Kostic AD
    Annu Rev Pathol; 2017 Jan; 12():217-244. PubMed ID: 27959634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas System: A Potential Technology for the Prevention and Control of COVID-19 and Emerging Infectious Diseases.
    Ding R; Long J; Yuan M; Jin Y; Yang H; Chen M; Chen S; Duan G
    Front Cell Infect Microbiol; 2021; 11():639108. PubMed ID: 33968799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconsidering the need for gain-of-function research on enhanced potential pandemic pathogens in the post-COVID-19 era.
    Shinomiya N; Minari J; Yoshizawa G; Dando M; Shang L
    Front Bioeng Biotechnol; 2022; 10():966586. PubMed ID: 36091454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives.
    Mahmud I; Garrett TJ
    J Am Soc Mass Spectrom; 2020 Oct; 31(10):2013-2024. PubMed ID: 32880453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.